Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 BFAM Q1 2026 Earnings EPS Beats Estimates on Operational Strength ADP Q1 2026 Earnings EPS Beat Amidst Steady Demand for HCM Solutions VRME Q4 2025 Earnings EPS Misses Estimates as Stock Edges Lower XMTR Q1 2026 Earnings EPS Beats Estimates Stock Reacts Positively